MORE Health Announces Partnership with Fox Chase Cancer Center to offer Patients Remote Second Opinions
Feb 19, 2019, 08:00 ET
SAN MATEO, Calif., Feb. 19, 2019 /PRNewswire/ -- Fox Chase Cancer Center and MORE Health, a global healthcare company, announced a cutting-edge partnership that gives patients from across the world access to the nationally ranked physicians of Fox Chase Cancer Center through MORE Health's Physician Collaboration Platform™.
MORE Health, through its prestigious network of tertiary and quaternary Academic Medical Centers and esteemed physician specialists, delivers a sophisticated version of medical second opinion for its patients. It's called a collaborative diagnosis (or Co-Diagnosis®). The Co-Diagnosis® service is delivered by a full-featured, intuitive and HIPAA-compliant online platform, which empowers physicians to efficiently deliver a diagnosis and treatment plan to patients in collaboration with their treating physicians in their home countries.
"This collaboration with MORE Health's innovative platform will allow us to reach patients in any location at any time. We look forward to the opportunities this will bring for our doctors and the benefits it will bring to patients everywhere," said Richard I. Fisher, MD, president & CEO of Fox Chase Cancer Center.
Fox Chase Cancer Center, part of the Temple University Health System, is committed to clinical excellence, research expertise, and community health. These initiatives earned them a National Cancer Institute (NCI) designation as one of the first comprehensive cancer centers in the country and one of only 50 in the nation to earn this full designation by the federal government's principal agency for cancer research and training. Their physicians offer patients state-of-the-art and best practice treatments as well as clinical trials.
"We are excited to partner with Fox Chase Cancer Center using our innovative platform," said Ted Bukowski, MORE Health SVP, Provider Partnerships. "The landscape of 21st century medicine allows for best in class care without barriers or borders, and MORE Health is proud to be leading that innovation."
Since 2013, MORE Health has helped thousands of patients around the world access care in the US. Through this partnership, their patients are able to access even more of the world's most preeminent doctors and specialists.
About Fox Chase Cancer Center
The Hospital of Fox Chase Cancer Center and its affiliates (collectively "Fox Chase Cancer Center"), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation's first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center's nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
About MORE Health
MORE Health, a global digital healthcare company, provides patients with access to the best physicians in the world when needed the most: when faced with a critical, potentially life-changing illness. Our collaborative approach to diagnosis puts the patient at the center of the process – empowering them to make informed decisions regarding their own healthcare. Offering all of the benefits of a second opinion, we ensure that the attending doctor and our expert physician specialist are aligned by jointly developing a diagnosis and treatment plan on our proprietary, cloud-based and HIPAA-compliant Physician Collaboration Platform, thus minimizing errors while also resolving potential conflicts regarding the diagnosis and treatment plan development. Learn more at https://morehealth.com.
SOURCE MORE Health
Share this article